Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2438]

One-half of patients with low-risk prostate cancer switch from active surveillance to active treatment

One-half of patients with low-risk prostate cancer switch from active surveillance to active treatment

Biomarkers of biochemical recurrence in prostate adenocarcinoma

Biomarkers of biochemical recurrence in prostate adenocarcinoma

Patients helping researchers to advance treatments for prostate cancer

Patients helping researchers to advance treatments for prostate cancer

Fear of cancer recurrence remains for certain prostate cancer survivors long after treatment

Fear of cancer recurrence remains for certain prostate cancer survivors long after treatment

Researchers pinpoint how PARP inhibitors combat BRCA1 and BRCA2 tumour cells

Researchers pinpoint how PARP inhibitors combat BRCA1 and BRCA2 tumour cells

New blood test improves prostate cancer screening

New blood test improves prostate cancer screening

Advanced bladder cancers respond to immunotherapy regardless of gene mutation status

Advanced bladder cancers respond to immunotherapy regardless of gene mutation status

Reducing data-transfer error in radiation therapy

Reducing data-transfer error in radiation therapy

NICE - UK issues MedTech innovation briefing on 'Trublood®- Prostate' for precision non-invasive prostate cancer diagnosis

NICE - UK issues MedTech innovation briefing on 'Trublood®- Prostate' for precision non-invasive prostate cancer...

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer

FDA grants regular approval to enfortumab vedotin-ejfv for locally advanced or metastatic urothelial cancer

More from ecancer